Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by longonMJon Sep 10, 2018 3:07pm
128 Views
Post# 28592283

RE:RE:ACB ahead of the game.

RE:RE:ACB ahead of the game. As has already been mentioned many times here before, simply looking at the share price is very misleading.

Especially in this case where Aurora now has about double the number of outstanding shares after all of their recent acquisitions, including the big 2 of CMED and Leaf.  So, I believe their current market cap is back in pretty much the same ball park as where it was when their share price was at $15.20.

Actually, when you compared the current market cap of ACB to Weed, it looks like Canopy is way overvalued as compared to where Aurora is trading at right now.  Especially if you factor in the over 100M additional new shares which Canopy will have to issued to Constellation resulting in them having a market cap triple to what Aurora currently has.

greenup wrote: Let's see, WEED is trading at almost double of its previous 52-week peak, APH is back at its 52 week high, ACB is still down 50% from its 52 week high.

Let the numbers speak for themselves.

EOM

TheRock79 wrote: Consolidation will be inevitable in this industry to create 3 giants. ACB seems to be buying the best and the biggest early on at a low cost. The weed and APH will have no choice to buy others at one point and dilute themselves. I’m an investor in all 3  but acb is starting to be very attractive 




Bullboard Posts